Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

28.08

Margin Of Safety %

Put/Call OI Ratio

0.21

EPS Next Q Diff

EPS Last/This Y

1.41

EPS This/Next Y

0.07

Price

5.36

Target Price

21.75

Analyst Recom

1

Performance Q

-6.38

Relative Volume

0.6

Beta

1.12

Ticker: ABEO




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-11-13ABEO4.530.260.4376450
2025-11-14ABEO4.470.263.6176808
2025-11-17ABEO4.510.287.9378227
2025-11-18ABEO4.490.320.0380796
2025-11-19ABEO4.20.320.2081191
2025-11-20ABEO4.230.320.0581587
2025-11-21ABEO4.470.320.1181947
2025-11-24ABEO4.60.121.2965767
2025-11-25ABEO4.880.141.4467615
2025-11-26ABEO5.160.190.3672864
2025-12-01ABEO4.780.190.0773081
2025-12-02ABEO4.550.190.1073888
2025-12-03ABEO4.740.190.0173905
2025-12-04ABEO4.860.191.4773935
2025-12-05ABEO4.880.190.0074267
2025-12-08ABEO5.120.191.2274243
2025-12-09ABEO5.220.201.5876354
2025-12-10ABEO5.460.220.0078193
2025-12-11ABEO5.510.210.0181761
2025-12-12ABEO5.360.210.3482604
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-11-13ABEO4.54-8.2- -0.44
2025-11-14ABEO4.4744.1- -0.15
2025-11-17ABEO4.52-7.6- -0.14
2025-11-18ABEO4.49-7.6- -0.14
2025-11-19ABEO4.20-7.6- -0.14
2025-11-20ABEO4.23-7.6- -0.14
2025-11-21ABEO4.48-7.6- -0.14
2025-11-24ABEO4.60-7.6- -0.14
2025-11-25ABEO4.88-7.6- -0.14
2025-11-26ABEO5.16-7.6- -0.23
2025-12-01ABEO4.78-7.6- -0.14
2025-12-02ABEO4.55-7.6- -0.14
2025-12-03ABEO4.73-7.6- -0.14
2025-12-04ABEO4.86-7.6- -0.14
2025-12-05ABEO4.87-7.6- -0.14
2025-12-08ABEO5.13-7.6- -0.14
2025-12-09ABEO5.24-7.6- -0.14
2025-12-10ABEO5.24-7.6- -0.14
2025-12-11ABEO5.52-7.6- -0.14
2025-12-12ABEO5.36-7.6- -0.14
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-11-13ABEO-5.548.1622.66
2025-11-14ABEO-5.488.1622.24
2025-11-17ABEO-6.27-1.5921.05
2025-11-18ABEO-6.27-1.5921.05
2025-11-19ABEO-6.27-1.5921.05
2025-11-20ABEO-6.27-1.5921.05
2025-11-21ABEO-6.27-1.5921.05
2025-11-24ABEO-6.271.1121.04
2025-11-25ABEO-6.291.1121.04
2025-11-26ABEO-6.291.1127.63
2025-12-01ABEO-6.251.1427.63
2025-12-02ABEO-6.251.1427.63
2025-12-03ABEO-6.251.1427.63
2025-12-04ABEO-6.251.1427.63
2025-12-05ABEO-6.251.1427.63
2025-12-08ABEO-4.841.1527.63
2025-12-09ABEO-4.841.1527.63
2025-12-10ABEO-4.841.1528.08
2025-12-11ABEO-4.841.1528.08
2025-12-12ABEO-4.841.1528.08
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

[stock_market_widget type="chart" template="candlestick" assets="ABEO" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

-0.1

Avg. EPS Est. Current Quarter

-0.34

Avg. EPS Est. Next Quarter

-0.1

Insider Transactions

-4.84

Institutional Transactions

1.15

Beta

1.12

Average Sales Estimate Current Quarter

5

Average Sales Estimate Next Quarter

18

Fair Value

Quality Score

95

Growth Score

29

Sentiment Score

67

Actual DrawDown %

94.4

Max Drawdown 5-Year %

-97.3

Target Price

21.75

P/E

4.6

Forward P/E

PEG

P/S

726.17

P/B

1.64

P/Free Cash Flow

EPS

1.17

Average EPS Est. Cur. Y​

-0.14

EPS Next Y. (Est.)

-0.07

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

20587.5

Relative Volume

0.6

Return on Equity vs Sector %

21.2

Return on Equity vs Industry %

36.2

EPS 1 7Days Diff

EPS 1 30Days Diff

0.31

EBIT Estimation

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”ABEO” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ABEO” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ABEO” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ABEO” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ABEO” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ABEO” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ABEO” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
Abeona Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 136
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is pz-cel, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
stock quote shares ABEO – Abeona Therapeutics Inc Stock Price stock today
news today ABEO – Abeona Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ABEO – Abeona Therapeutics Inc yahoo finance google finance
stock history ABEO – Abeona Therapeutics Inc invest stock market
stock prices ABEO premarket after hours
ticker ABEO fair value insiders trading